[1] Isfort M,Stevens SC,Schaffer S,et al.Metabolic dysfunction in diabetic cardiomyopathy [J]. Heart Fail Rev,2014,19(1):35-48.[2] Battiprolu PK,Lopez-Crisosto C,Wang ZV,et al.Diabetic car-diomyopathy and metabolic remodeling of the heart[J].Life Sci,2013,92(11):609-615.[3] 闫德祺,闫英男,阿力木·买买提,等.苦参活性成分的抗肿瘤作用机制研究 进展[J].现代生物医学进展,2014,14(24):4776-4779.[4] 刘 群.实验性2型糖尿病心肌病大鼠模型建立的方法[J].临床心血管病杂志,2014,30(3):254-257.[5] 董世芬,洪 缨,樊江波,等.实验性2 型糖尿病心肌病大鼠模型的建立与评价[J].中国实验动物学报,2009,17(4):245-251.[6] Fang ZY,Prins JB,Marwick TH.Diabetic cardiomyopathy:evidence,mechanisms,and therapeutic implications[J].Endocr Rev,2004,25(4): 543 -547.[7] Mandavia CH,Pulakat L,DeMarco V,et al.Over-nutrition,obesity and metabolic cardiomyopathy[J].Metabolism,2012,61(9):1205-1210.[8] Hayden MR,Tyagi SC.Myocardial redox stress and remodeling inmetabolic syndrome,type 2 diabetes mellitus,and congestive heart failure[J].Med Sci -Monit,2003,9(7):SR35-52.[9] Collier P,McDonald KM. The role of renin angiotensin system intervention in stage B heart failure [J].Heart Fail Clin,2012,8(2):225-236.[10] Balliprolu PK,Lopez-Crisoslo C,Wang ZV,et al.Diabelic cardiomyopathy and melabolic of the heart [J].Life Sci,2013,92(11):609-615.[11] Adameova A,Dhalla NS.Role of microangiopathy in diabertic cardiomyopathy [J].Heart Fail Rev,2014,19(1):25-33.[12] Fancher IS,Dick GM,Hollander JM.Diabetes mellites reduces the function and expression of ATP-dependent K+ channels in cardiac mitochondria[J].Life Sci,2013,92(11):664-668.[13] Liu JW,Liu D,Cui KZ,et al.Recent advances in understanding the biochemical and molecular mechanism of diabetic cardiomyopathy[J].Biochem Biophys Res Commun,2012,427(3):441-443.[14] Bell DS.Diabetic cardiomyopathy[J].Diabetes Care,2003,26(10):2791-2795.[15] 席晓慧,王福文,牟艳玲.糖尿病心肌病的药物治疗研究进展[J].山东医药,2014,54(5):93-95. |